Brazil’s health regulator proposes suspending vaccination of pregnant women with Janssen and AstraZeneca

In May, ANVISA had recommended the suspension of AstraZeneca's use in this group. On Friday, July 2, the agency extended the guidance to Janssen's vaccine.

RIO DE JANEIRO, BRAZIL - The National Health Regulator (ANVISA) proposed to suspend the application of vaccines against Covid-19 from both AstraZeneca and Janssen in pregnant women. The recommendation applies to immunizers that use adenoviral vectors. Thus, Brazilian pregnant women should receive doses from either Pfizer or Coronavac.

In May, the agency had already recommended the suspension of AstraZeneca's use in this group. In a statement released last Friday, July 2, the agency extended the orientation to Janssen's vaccine, which arrived in the country at the end of June.

Last April, pregnant women were included in the priority . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?